KDM5A and acute myeloid leukemia: Additionally, both NUP98::KDM5A and NUP98::NSD1 AML show upregulation of targets of E2F (E2F transcription factor 1) and FLT3, and downregulation of targets of TP53 and HDAC (Noort et al., 2021).